Estrogen-induced retinoic acid receptor α1 gene expression:: Role of estrogen receptor Sp1 complex

被引:109
作者
Sun, GL [1 ]
Porter, W [1 ]
Safe, S [1 ]
机构
[1] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA
关键词
D O I
10.1210/me.12.6.882
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Retinoic acid receptor alpha 1 (RAR alpha 1) gene expression is induced by 17 beta-estradiol (E-2) in estrogen receptor (ER)-positive breast cancer cells, and the -100 to -49 region of the RAR alpha 1 gene promoter was previously shown to be required for E-2-responsiveness. This region of the RAR alpha 1 promoter was further analyzed using the following oligonucleotides: -100 to -49 (RAR4); -79 to -56 (RAR3); -79 to -49 (RAR2); -100 to -58 (RAR1); and their derived promoter reporter constructs (pRAR4, pRAR3, pRAR2, and pRAR1). in transient transfection studies in MCF-7 human breast cancer cells, pRAR2 and pRAR1 were E-2-responsive; both of the RAR alpha 1 gene promoter inserts contained two GC-rich sites and bound Spl protein in gel mobility shift assays. Using wild-type [P-32]RAR2 and oligonucleotides mutated in one or both GC-rich sites, it was shown that ER enhanced Sp1 binding to both sites, but a ternary ER-Sp1-DNA complex was not observed in gel mobility shift assays. In transient transfection assays, each of the GC-rich motifs were sufficient for E-2-induced transactivation. In ER-negative MDA-MB-231 cells transiently transfected with pRAR2, E-2 responsiveness was observed only in cells cotransfected with wild-type ER or 11C-ER containing a deletion of the DNA-binding domain beet not with ER variants that express activation function-1 (AF-1) or AF-2. Using a similar approach, it was shown that the GC-rich sites in RAR1 were also sufficient for ER activation. These results demonstrate that interaction of a transcriptionally active ER/Sp1 complex with GC-rich motifs is required for hormone inducibility of the downstream region of the RAR alpha 1 gene promotor.
引用
收藏
页码:882 / 890
页数:9
相关论文
共 50 条
  • [1] ALLEGRETTO EA, 1993, J BIOL CHEM, V268, P26625
  • [2] RETINOIC ACID RECEPTORS AND RETINOID X-RECEPTORS - INTERACTIONS WITH ENDOGENOUS RETINOIC ACIDS
    ALLENBY, G
    BOCQUEL, MT
    SAUNDERS, M
    KAZMER, S
    SPECK, J
    ROSENBERGER, M
    LOVEY, A
    KASTNER, P
    GRIPPO, JF
    CHAMBON, P
    LEVIN, AA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (01) : 30 - 34
  • [3] Chemoprevention of mammary carcinogenesis in the rat: Combined use of raloxifene and 9-cis-retinoic acid
    Anzano, MA
    Peer, CW
    Smith, JM
    Mullen, LT
    Shrader, MW
    Logsdon, DL
    Driver, CL
    Brown, CC
    Roberts, AB
    Sporn, MB
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (02) : 123 - 125
  • [4] DAWSON MI, 1995, CANCER RES, V55, P4446
  • [5] STUDY OF AN ANTIESTROGENIC EFFECT OF RETINOIC ACID IN MCF-7 CELLS
    DEMIRPENCE, E
    PONS, M
    BALAGUER, P
    GAGNE, D
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 183 (01) : 100 - 106
  • [6] DEMIRPENCE E, 1994, CANCER RES, V54, P1458
  • [7] Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells:: Role of estrogen receptor Sp1 complex formation
    Duan, R
    Porter, W
    Safe, S
    [J]. ENDOCRINOLOGY, 1998, 139 (04) : 1981 - 1990
  • [8] DUBIK D, 1992, ONCOGENE, V7, P1587
  • [9] Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-alpha 1 promoter via a novel sequence
    Elgort, MG
    Zou, A
    Marschke, KB
    Allegretto, EA
    [J]. MOLECULAR ENDOCRINOLOGY, 1996, 10 (05) : 477 - 487
  • [10] Fitzgerald P, 1997, CANCER RES, V57, P2642